CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $182,793
- in 3 filings
Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-04 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units (RSUs) | −1,042 | 4,167 | ||
| 2019-11-21 | Barrett Elizabeth A. Chief Executive Officer | Purchase | +7,530 | $28.00 | $211K | 16,548 |
| 2019-11-20 | Barrett Elizabeth A. Chief Executive Officer | Purchase | +7,470 | $28.00 | $209K | 9,018 |
| 2019-11-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion | +1,042 | 3,793 | ||
| 2019-11-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −354 | $28.41 | $10K | 3,439 |
| 2019-11-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,042 | 7,291 | ||
| 2019-11-19 | Schoenberg Mark Chief Medical Officer | Purchase | +1,960 | $28.17 | $55K | 7,967 |
| 2019-11-15 | Barrett Elizabeth A. Chief Executive Officer | Purchase | +1,548 | $26.00 | $40K | 1,548 |
| 2019-11-14 | Mullennix Stephen Chief Operating Officer | Exercise or conversion | +1,759 | 8,291 | ||
| 2019-11-14 | Mullennix Stephen Chief Operating Officer | Sale | −608 | $26.00 | $16K | 7,683 |
| 2019-11-14 | Mullennix Stephen Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −1,759 | 8,796 | ||
| 2019-09-04 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +1,041 | 6,350 | ||
| 2019-09-04 | Schoenberg Mark Chief Medical Officer | Sale | −343 | $33.92 | $12K | 6,007 |
| 2019-09-04 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units (RSUs) | −1,041 | 5,209 | ||
| 2019-08-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion | +4,167 | 4,167 | ||
| 2019-08-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −1,416 | $33.07 | $47K | 2,751 |
| 2019-08-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −4,167 | 8,333 | ||
| 2019-08-15 | Mullennix Stephen Chief Operating Officer | Sale | −608 | $31.65 | $19K | 6,532 |
| 2019-08-14 | Mullennix Stephen Chief Operating Officer | Exercise or conversion | +1,759 | 7,140 | ||
| 2019-08-14 | Mullennix Stephen Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −1,759 | 10,555 |
Page 24 of 25 · 496 trades